Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL
ClinicalTrials.gov study NCT00435084. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02100852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
ClinicalTrials.gov study NCT03283137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
ClinicalTrials.gov study NCT04502394. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)
ClinicalTrials.gov study NCT04716075. IPD Sharing: NO. Countries: 1. Publications: 0.
CLL Empirical Antibiotic Regimen
ClinicalTrials.gov study NCT01279252. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
ClinicalTrials.gov study NCT04240704. IPD Sharing: NO. Countries: 7. Publications: 0.
A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00499239. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation
ClinicalTrials.gov study NCT02535286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00800566. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
ClinicalTrials.gov study NCT02229422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
ClinicalTrials.gov study NCT05718869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi
ClinicalTrials.gov study NCT06466122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax
ClinicalTrials.gov study NCT05317936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
ClinicalTrials.gov study NCT01703364. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01653717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CLL Therapy Approaches in Russia
ClinicalTrials.gov study NCT05140369. IPD Sharing: YES. Countries: 1. Publications: 0.
Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment
ClinicalTrials.gov study NCT01521689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00801060. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
ClinicalTrials.gov study NCT00559624. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.